Showing 4681-4700 of 8668 for: Cochrane Systematic Reviews Back
- Luteal phase support in assisted reproduction cycles
Cochrane Systematic Reviews, 17-Jul-2008
The aspiration of the granulosa cells that surround the oocyte and the use of gonadotropin releasing hormone agonists (GnRHa) during assisted reproduction technology (ART) treatment can interfere with the production, during the luteal phase, of progestero
- Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer
Cochrane Systematic Reviews, 29-Jun-2016
Ovarian cancer is seventh most common cancer in women worldwide. Approximately 1.3% of women will be diagnosed with ovarian cancer at some point during their life time. The majority of tumours arise from surface of the ovary (epithelial). Two thirds of th
- Lycopene for the prevention of prostate cancer
Cochrane Systematic Reviews, 25-Oct-2011
Prostate cancer is a common cause of death in developed countries, yet the benefits of screening for prostate cancer still remain controversial. A prostate-specific antigen (PSA) test result greater than 4 ng/mL (nanograms/millilitre) has commonly been us
- Lymphadenectomy for the management of endometrial cancer
Cochrane Systematic Reviews, 2-Oct-2017
This is an update of a previous Cochrane review published in Issue 1, 2010 and updated in Issue 9, 2015. The role of lymphadenectomy in surgical management of endometrial cancer remains controversial. Lymph node metastases can be found in approximately 10
- Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation
Cochrane Systematic Reviews, 15-Mar-2019
Kidney transplantation is the optimal treatment for end-stage kidney disease. Retrieval, transport and transplant of kidney grafts causes ischaemia reperfusion injury. The current accepted standard is static cold storage (SCS) whereby the kidney is stored
- Macrolide antibiotics for bronchiectasis
Cochrane Systematic Reviews, 15-Mar-2018
Bronchiectasis is a chronic respiratory disease characterised by abnormal and irreversible dilatation and distortion of the smaller airways. Bacterial colonisation of the damaged airways leads to chronic cough and sputum production, often with breathlessn
- Macrolide antibiotics for cystic fibrosis
Cochrane Systematic Reviews, 14-Nov-2012
Macrolide antibiotics may have a modifying role in diseases which involve airway infection and inflammation, like cystic fibrosis.
- Macrolides for diffuse panbronchiolitis
Cochrane Systematic Reviews, 25-Jan-2015
Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. Macrolides, a class of antibiotics, have been used as the main treatment for DPB, based on evidence from retrospective and non-randomised studies.
- Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults
Cochrane Systematic Reviews, 11-Dec-2017
Chancroid is a genital ulcerative disease caused by Haemophilus ducreyi. This microorganism is endemic in Africa, where it can cause up to 10% of genital ulcers. Macrolides may be an effective alternative to treat chancroid and, based on their oral admini
- Macrolides versus placebo for chronic asthma
Cochrane Systematic Reviews, 22-Nov-2021
Asthma is a chronic disease in which inflammation of the airways causes symptomatic wheezing, coughing and difficult breathing. Macrolides are antibiotics with antimicrobial and anti-inflammatory activities that have been explored for the long-term contro
- Macular grid laser photocoagulation for branch retinal vein occlusion
Cochrane Systematic Reviews, 11-May-2015
Branch retinal vein occlusion (BRVO) is the second most common cause of retinal vascular abnormality after diabetic retinopathy. Persistent macular oedema develops in 60% of eyes with a BRVO. Untreated, only 14% of eyes with chronic macular oedema will ha
- Macular translocation for neovascular age-related macular degeneration
Cochrane Systematic Reviews, 6-Apr-2009
Macular translocation has been proposed by vitreoretinal surgeons to displace the neuroretinal tissue onto healthy retinal pigment epithelium and choroid when the macula has been invaded by subretinal neovascularisation.
- Magnesium for acute traumatic brain injury
Cochrane Systematic Reviews, 8-Oct-2008
Acute traumatic brain injury is a leading cause of death and disability in young adults. Numerous pharmacological and non-pharmacological tools have been investigated and considered as potential mechanisms for improving neurological outcome. Magnesium has
- Magnesium for alcohol withdrawal
Cochrane Systematic Reviews, 28-May-2013
Patients have been given magnesium to treat or prevent alcohol withdrawal syndrome (AWS). Evidence to support this practice is limited, and is often based on the controversial link between hypomagnesaemia and AWS.
- Magnesium for skeletal muscle cramps
Cochrane Systematic Reviews, 21-Sep-2020
Skeletal muscle cramps are common and often occur in association with pregnancy, advanced age, exercise or motor neuron disorders (such as amyotrophic lateral sclerosis). Typically, such cramps have no obvious underlying pathology, and so are termed idiop
- Magnesium for treating sickle cell disease
Cochrane Systematic Reviews, 9-Sep-2019
Sickle cell disease is an autosomal recessive inherited haemoglobinopathy which causes painful vaso-occlusive crises due to sickle red blood cell dehydration. Vaso-occlusive crises are common painful events responsible for a variety of clinical complicati
- Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour
Cochrane Systematic Reviews, 31-May-2013
Magnesium maintenance therapy is one of the types of tocolytic therapy used after an episode of threatened preterm labour (usually treated with an initial dose of tocolytic therapy) in an attempt to prevent the onset of further preterm contractions.
- Magnesium sulfate for persistent pulmonary hypertension of the newborn
Cochrane Systematic Reviews, 16-Feb-2010
Persistent pulmonary hypertension of the newborn (PPHN) occurs in approximately 1.9 per 1000 newborns and may be more frequent in developing countries. There is strong evidence for the use of inhaled nitric oxide (iNO) and extracorporeal membrane oxygenat
- Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
Cochrane Systematic Reviews, 24-Jan-2000
Treatment of acute asthma is based on rapid reversal of bronchospasm and arresting airway inflammation. There is some evidence that intravenous magnesium can provide additional bronchodilation when given in conjunction with standard bronchodilating agents
- Magnesium sulphate and other anticonvulsants for women with pre‐eclampsia
Cochrane Systematic Reviews, 10-Nov-2010
Eclampsia, the occurrence of a seizure (fit) in association with pre-eclampsia, is rare but potentially life-threatening. Magnesium sulphate is the drug of choice for treating eclampsia. This review assesses its use for preventing eclampsia.